Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
申请人:Nogra Pharma Limited
公开号:US10016381B2
公开(公告)日:2018-07-10
The present invention relates to compounds comprising the general formula (I), in which R1 and R2, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR3, —CH(OR3)COOH, in which R3 is selected from H, phenyl, benzyl, —CF3 or —CF2CF3, vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
本发明涉及包含通式(I)的化合物,其中 R1 和 R2(可以相同或不同)选自-H 或具有 1 至 6 个碳原子的直链或支链烷基,或共同形成具有 5 或 6 个原子的芳香族或脂肪族环;Y 和 Z(可以相同或不同)选自-H、-OH、-COOH、-OR3、-CH(OR3)COOH 组,其中 R3 选自 H、苯基、苄基、-CF3 或-CF2CF3、乙烯基、烯丙基和具有 1 至 6 个碳原子的直链或支链烷基。